Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-07
DOI
10.1038/srep11853
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia
- (2015) Francesca Chiarini et al. Oncotarget
- Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling
- (2015) Cundong Fan et al. Oncotarget
- Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma
- (2014) Naoshad Mohammad et al. Molecular Cancer
- Potential use of Folate-appended Methyl-β-Cyclodextrin as an Anticancer Agent
- (2013) Risako Onodera et al. Scientific Reports
- Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycation
- (2013) Suresh K. Kesavan et al. Scientific Reports
- Curcumin–cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer
- (2012) N Rocks et al. BRITISH JOURNAL OF CANCER
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- The global breast cancer burden
- (2012) John R Benson et al. Future Oncology
- Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest
- (2012) Fabiana Casanova et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl
- (2012) Guanyu Wang et al. PLoS One
- Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy
- (2011) Haoran Qian et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Diet-induced obesity increases melanoma progression: Involvement of Cav-1 and FASN
- (2011) Vimal Pandey et al. INTERNATIONAL JOURNAL OF CANCER
- p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury
- (2011) Joyce M. Velez et al. PLoS One
- Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX
- (2010) Jean-Christophe Marine CANCER CELL
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: Drug encapsulation and in vitro evaluation
- (2009) Cheng Zheng et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models
- (2009) Ratna Kumari et al. Molecular Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search